secwatch.observer — SEC 8-K summary
======================================

Issuer:     IO Biotech, Inc. (IOBTQ)
CIK:        0001865494
Form:       8-K
Filed at:   2023-06-09T23:59:59+00:00
Accession:  0001193125-23-164443
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

IO Biotech shareholders elect directors and approve officer exculpation amendment at annual meeting
--------------------------------------------------------------------------------

- Priyanka Belawat and Christian Elling elected as Class II directors until 2026 annual meeting.
- Amendment to Certificate of Incorporation to provide officer exculpation approved: 20,021,960 for, 115,161 against.
- Ratification of EY Godkendt Revisionspartnerselskab as independent auditor for FY2023 approved: 20,815,596 for, 111,302 against.
- Broker non-votes were 789,675 on director elections and the exculpation proposal.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1865494/000119312523164443/0001193125-23-164443-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1865494/000119312523164443/d457839d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-164443

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer